@FiercePharma: Catch this week's issue of FiercePharmaMarketing here. Issue | Follow @FiercePharma
@TracyStaton: Novartis nabs Merck exec Bruno Strigini to head up oncology business. More | Follow @TracyStaton
@EricPFierce: RT from @FiercePharma: Smells like team spirit: AstraZeneca CEO says Pfizer fight has it pumped to perform. Story | Follow @EricPFierce
@CarlyHFierce: Out with the old, in with the new: Merck, GSK, others put established drugs on the block. News | Follow @CarlyHFierce
@JustinHFierce: #NPPCWPX THE WORLD PORK EXPO HAS A MEDIA ROOM. | Follow @JustinHFierce
> The Novartis ($NVS) blood cancer drug Jakavi did a better job of controlling polycythemia vera, an incurable bone marrow cancer, compared with best available therapy, a study found. Release
> Valeant Pharmaceuticals ($VRX) CEO Michael Pearson committed $30 million in donations to the engineering school at Duke University, his alma mater. Report
> A Philadelphia judge upheld an $11 million verdict against Johnson & Johnson's ($JNJ) Janssen unit in a Topamax liability case. Report
> India's Glenmark Pharmaceuticals threw open the doors on its new antibody manufacturing facility in Switzerland. Release
> Biotech companies fear that a Supreme Court decision in a tech-company case could undermine their method patents. Report
> Price caps in the EU are undercutting generics makers and could ultimately cause companies to pull out of certain markets or cut jobs, a trade group says. Report
Medical Device News
@FierceMedDev: Singapore team designs nanotech glaucoma treatment for sustained release. Story from FierceDrugDelivery | Follow @FierceMedDev
@VarunSaxena2: The EU continues to talk medical device reform. What will the finished regulations look like? More from The National Law Review | Follow @VarunSaxena2
@MichaelGFierce: 'Quadrapeutics' method delivers chemo, nanogold, infrared light and radiation to kill cancer. More from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Learning a second language could help ward off dementia, say researchers @UniofEdinburgh. More | Follow @EmilyWFierce
> GE wins FDA approval for automated breast imaging system . News
> Pixium Vision looks to raise $45M in European IPO. Article
> Former ArthroCare top execs convicted of securities fraud scheme. Article
Biotech News
@FierceBiotech: Trending--Sanofi CEO Viehbacher now calls beloved Boston biotech hub his home. More | Follow @FierceBiotech
@JohnCFierce: No. 1 - $31M; No. 2 - $8M: 2013's 10 best-compensated R&D chiefs in biopharma. Report | Follow @JohnCFierce
@DamianFierce: Science pays: 2013's 10 best-compensated R&D chiefs in biopharma. Feature | Follow @DamianFierce
@EmilyMFierce: Genetically engineered malaria parasite could expedite vaccine development. ICYMI from FierceBiotech Research | Follow @EmilyMFierce
> Biotech boom or no, many startups are staying virtual. Story
> Analyst prods Amgen to join the Big Pharma breakup party. More
> Biotech claims a dubious Alzheimer's 'breakthrough.' Item
> Trevi, Complexa bag $38M in VC cash to hit the gas on R&D. Article
> Shire sweetens its arGEN-X deal with a $20M investment. News
Drug Delivery News
> 'Quadrapeutics' method delivers chemo, nanogold, infrared light and radiation to kill cancer. More
> Singapore team designs nanotech glaucoma treatment for sustained release. Article
> First cheek-bound film for opioid dependence nears PDUFA date. Report
> Investors watch RNA therapy companies for signs of future profits. Item
> FDA approves first nasally delivered gel for 'Low T.' Story
Diagnostics News
> Quest and Memorial Sloan-Kettering team for next-generation gene sequencing. Report
> Five urine biomarkers may offer a new way to spot male infertility. Item
> Provista broadens ASU cancer biomarker licensing deal. More
> NanoString to produce companion test for Celgene's blockbuster cancer drug Revlimid. Article
> Almac at ASCO: Dx spots ovarian cancer patients for whom Roche's Avastin would hurt. Story
Pharma Marketing News
> Pfizer launches next new Lipitor copay program, Medicare and ACA included. Report
> GlaxoSmithKline's Chinese reps demand to be repaid for bribes, FT reports. More
> Novartis, Merck KGaA use digital tracking in MS patients to up their competitive game. Story
> AstraZeneca's Crestor gets a boost from Cigna data-crunching deal. Article
> Pfizer launches next new Lipitor copay program, Medicare and ACA included. More
And Finally... Merck & Co. ($MRK) CEO Kenneth Frazier said the company is proud to be an American, but wants to pay lower taxes just as the companies re-domiciling outside the U.S. do. Report